These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35146717)

  • 1. [RPE65-associated retinal dystrophies: gene therapy preserves vision].
    Gerhardt MJ; Michalakis S; Rudolph G; Priglinger C; Priglinger SG
    MMW Fortschr Med; 2022 Feb; 164(Suppl 4):40-41. PubMed ID: 35146717
    [No Abstract]   [Full Text] [Related]  

  • 2. [RPE65-retinal Dystrophies: From the Spectrum of the Clinical Picture to Gene Therapy].
    Stingl K; Priglinger C
    Klin Monbl Augenheilkd; 2024 Mar; 241(3):257-258. PubMed ID: 38508213
    [No Abstract]   [Full Text] [Related]  

  • 3. Dog models for blinding inherited retinal dystrophies.
    Petersen-Jones SM; Komáromy AM
    Hum Gene Ther Clin Dev; 2015 Mar; 26(1):15-26. PubMed ID: 25671556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of
    Kahraman NS; Öner A; Özkul Y; Dündar M
    Turk J Ophthalmol; 2022 Aug; 52(4):270-275. PubMed ID: 36017377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subretinal deposits in young patients treated with voretigene neparvovec-rzyl for RPE65-mediated retinal dystrophy.
    Lopez J; Borchert M; Lee TC; Nagiel A
    Br J Ophthalmol; 2023 Mar; 107(3):299-301. PubMed ID: 35835501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RPE65: role in the visual cycle, human retinal disease, and gene therapy.
    Cai X; Conley SM; Naash MI
    Ophthalmic Genet; 2009 Jun; 30(2):57-62. PubMed ID: 19373675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal dystrophies and gene therapy.
    Sundaram V; Moore AT; Ali RR; Bainbridge JW
    Eur J Pediatr; 2012 May; 171(5):757-65. PubMed ID: 22080959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy for Retinal Degeneration.
    Apte RS
    Cell; 2018 Mar; 173(1):5. PubMed ID: 29570997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials.
    Maguire AM; Russell S; Wellman JA; Chung DC; Yu ZF; Tillman A; Wittes J; Pappas J; Elci O; Marshall KA; McCague S; Reichert H; Davis M; Simonelli F; Leroy BP; Wright JF; High KA; Bennett J
    Ophthalmology; 2019 Sep; 126(9):1273-1285. PubMed ID: 31443789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specific gene therapy for hereditary retinal dystrophies - an update].
    Stieger K; Lorenz B
    Klin Monbl Augenheilkd; 2014 Mar; 231(3):210-5. PubMed ID: 24327302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Navigating the current landscape of clinical genetic testing for inherited retinal dystrophies.
    Lee K; Garg S
    Genet Med; 2015 Apr; 17(4):245-52. PubMed ID: 25790163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy.
    Kang C; Scott LJ
    Mol Diagn Ther; 2020 Aug; 24(4):487-495. PubMed ID: 32535767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new landscape of retinal gene therapy.
    Ku CA; Pennesi ME
    Am J Med Genet C Semin Med Genet; 2020 Sep; 184(3):846-859. PubMed ID: 32888388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.
    Russell S; Bennett J; Wellman JA; Chung DC; Yu ZF; Tillman A; Wittes J; Pappas J; Elci O; McCague S; Cross D; Marshall KA; Walshire J; Kehoe TL; Reichert H; Davis M; Raffini L; George LA; Hudson FP; Dingfield L; Zhu X; Haller JA; Sohn EH; Mahajan VB; Pfeifer W; Weckmann M; Johnson C; Gewaily D; Drack A; Stone E; Wachtel K; Simonelli F; Leroy BP; Wright JF; High KA; Maguire AM
    Lancet; 2017 Aug; 390(10097):849-860. PubMed ID: 28712537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Aspects in Gene Therapy for Inherited Retinal Diseases.
    Fischer MD; Bartz-Schmidt KU; Dimopoulos S; Herrmann P; Gerhardt M; Holz FG; Priglinger S
    Klin Monbl Augenheilkd; 2021 Mar; 238(3):267-271. PubMed ID: 33618387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement.
    Cideciyan AV; Jacobson SG; Beltran WA; Sumaroka A; Swider M; Iwabe S; Roman AJ; Olivares MB; Schwartz SB; Komáromy AM; Hauswirth WW; Aguirre GD
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):E517-25. PubMed ID: 23341635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for RPE65-mediated retinal dystrophies.
    Nagiel A
    Surv Ophthalmol; 2018; 63(3):445-446. PubMed ID: 29248533
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in the molecular understanding of canine retinal diseases.
    Petersen-Jones S
    J Small Anim Pract; 2005 Aug; 46(8):371-80. PubMed ID: 16119056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal Dystrophies and the Road to Treatment: Clinical Requirements and Considerations.
    Talib M; Boon CJF
    Asia Pac J Ophthalmol (Phila); 2020; 9(3):159-179. PubMed ID: 32511120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.
    Chiu W; Lin TY; Chang YC; Isahwan-Ahmad Mulyadi Lai H; Lin SC; Ma C; Yarmishyn AA; Lin SC; Chang KJ; Chou YB; Hsu CC; Lin TC; Chen SJ; Chien Y; Yang YP; Hwang DK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.